Free Trial
NASDAQ:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

Biotricity logo
$0.05 0.00 (-3.49%)
As of 10/9/2026 03:55 PM Eastern

About Biotricity Stock (NASDAQ:BTCY)

Advanced

Key Stats

Today's Range
$0.05
▼
$0.06
50-Day Range
$0.05
▼
$0.13
52-Week Range
$0.04
▼
$0.75
Volume
51,306 shs
Average Volume
52,631 shs
Market Capitalization
$1.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biotricity Inc. is a medical technology company focused on remote cardiac monitoring and connected healthcare. The company develops and provides technology designed to help physicians monitor patients outside traditional clinical settings, with the goal of supporting the diagnosis and management of cardiac conditions.

Its product portfolio includes wearable and mobile cardiac-monitoring solutions such as Bioflux, a real-time ambulatory cardiac monitoring system, and Biotres, a remote monitoring platform intended to support longer-term cardiac care. Biotricity also provides related software, data-management tools, and monitoring services that connect patients, healthcare providers, and clinical information.

Founded in 2013, Biotricity primarily serves healthcare providers and patients in the United States through its remote patient-monitoring and medical-device offerings. The company was founded and is led by Waqaas Al-Siddiq, who serves as chief executive officer.

AI Generated. May Contain Errors.

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BTCY Stock News Headlines

Biotricity Q3 2026 Earnings Call: Complete Transcript
No. 1 stock to cash in on the death of iPhone
Analyst Josh Baylin, who warned Congress about smartphones years before the iPhone launched, says the world's richest man may be building an iPhone rival he calls Starphone. Baylin points to FCC rulings, two trademarks filed the same day, multibillion-dollar spectrum deals, chip partnerships, and a string of posts from Elon Musk as evidence pointing to one conclusion. See the full research and the stock Baylin is watching now.tc pixel
Biotricity, Inc. (BTCY) Q3 2026 Earnings Call Transcript
Biotricity Inc.
See More Headlines

BTCY Stock Analysis - Frequently Asked Questions

Biotricity's stock was trading at $0.30 on January 1st, 2026. Since then, BTCY shares have decreased by 82.5% and is now trading at $0.0525.

Biotricity, Inc. (NASDAQ:BTCY) released its quarterly earnings data on Wednesday, February, 11th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.04. The firm earned $3.99 million during the quarter.
Read the conference call transcript
.

Shares of Biotricity reverse split on the morning of Monday, July 3rd 2023.The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Biotricity (BTCY) raised $15 million in an initial public offering on Thursday, August 26th 2021. The company issued 5,000,000 shares at a price of $3.00 per share. H.C. Wainwright & Co. acted as the underwriter for the IPO.

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Broadcom (AVGO), Micron Technology (MU) and Bank of America (BAC).

Company Calendar

Last Earnings
2/11/2026
Today
10/10/2026
Next Earnings (Estimated)
11/12/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:BTCY
Previous Symbol
OTCMKTS:BTCY
CIK
1630113
Fax
N/A
Employees
46
Year Founded
2014

Profitability

EPS (Trailing Twelve Months)
($0.14)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.09 million
Net Margins
-80.42%
Pretax Margin
-80.42%
Return on Equity
N/A
Return on Assets
-188.47%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.23
Quick Ratio
0.10

Sales & Book Value

Annual Sales
$12.06 million
Price / Sales
0.09
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.30) per share
Price / Book
-0.04

Miscellaneous

Outstanding Shares
20,075,000
Free Float
22,075,000
Market Cap
$1.05 million
Optionable
No Data
Beta
1.21

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:BTCY) was last updated on 10/10/2026 by MarketBeat.com Staff.
From Our Partners